Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2014
Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancerMatthew D Burstein, Anna Tsimelzon, Graham M Poage, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patientsJenny C Chang, Eric C Wooten, Anna Tsimelzon, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2011
Dicer-mediated upregulation of BCRP confers tamoxifen resistance in human breast cancer cellsJennifer Selever, Guowei Gu, Michael T Lewis, et al.Molecular Endocrinology (Baltimore, Md.)|January 15, 2013
Research resource: tissue- and pathway-specific metabolomic profiles of the steroid receptor coactivator (SRC) familyBrian York, Jørn V Sagen, Anna Tsimelzon, et al.Science Translational Medicine|May 6, 2021
A subset of cytotoxic effector memory T cells enhances CAR T cell efficacy in a model of pancreatic ductal adenocarcinomaVanaja Konduri, Sujith K Joseph, Tiara T Byrd, et al.Cell Metabolism|May 8, 2012
Ablation of steroid receptor coactivator-3 resembles the human CACT metabolic myopathyBrian York, Erin L Reineke, Jørn V Sagen, et al.NPJ Breast Cancer|May 1, 2020
BCL9/STAT3 regulation of transcriptional enhancer networks promote DCIS progressionHanan S Elsarraj, Yan Hong, Darlene Limback, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2019
Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without ChemotherapyCarmine De Angelis, Chandandeep Nagi, Cliff C Hoyt, et al.Molecular Cancer Research : MCR|August 18, 2019
Targeting the Mevalonate Pathway to Overcome Acquired Anti-HER2 Treatment Resistance in Breast CancerVidyalakshmi Sethunath, Huizhong Hu, Carmine De Angelis, et al.Proceedings of the National Academy of Sciences of the United States of America|October 30, 2016
FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancerXiaoyong Fu, Rinath Jeselsohn, Resel Pereira, et al.Pageof 6